首页|文拉法辛联合氟西汀对伴焦虑症状重度抑郁症患者的效果

文拉法辛联合氟西汀对伴焦虑症状重度抑郁症患者的效果

扫码查看
目的 探讨文拉法辛联合氟西汀对伴焦虑症状重度抑郁症(major depressive disorder,MDD)患者躯体症状、睡眠质量及血清 5-羟色胺(5-hydroxytryptamine,5-HT)、皮质醇(cortisol,Cor)和脑源性神经营养因子(brain-derived neurotrophic factor,BDNF)水平的影响。方法 将收治的149例MDD伴焦虑症状患者用数字表法随机分为对照组(74例)和研究组(75例)。对照组给予氟西汀治疗,研究组在对照组治疗的基础上给予文拉法辛治疗。比较2组治疗8周后的临床疗效、焦虑、抑郁、躯体症状、睡眠质量和血清5-HT、Cor和BDNF水平以及安全性。结果 治疗8周后,研究组的治疗有效率(97。33%)显著高于对照组(87。84%),P<0。05;研究组汉密尔顿焦虑量表(Hamilton anxiety scale,HAMA)、汉密尔顿抑郁量表(Hamilton depression scale,HAMD)评分均显著低于对照组(P<0。01);研究组躯体症状群量表(questionnaire-15,PHQ-15)、临床总体印象量表(clinical global impression-severity of illness,CGI-S)和匹兹堡睡眠质量指数(Pittsburgh sleep quality index,PSQI)评分均显著低于对照组(P<0。01);研究组5-HT、去甲肾上腺素(norepinephrine,NE)均显著高于对照组(P<0。01);研究组Cor显著低于对照组,BDNF显著高于对照组(P<0。01);2组各类不良反应发生率比较差异无统计学意义。结论 文拉法辛联合氟西汀治疗伴焦虑症状MDD患者疗效显著,能有效改善患者的焦虑、抑郁症状,躯体症状和睡眠质量;提高血清5-HT和BDNF水平,调节神经递质;抑制Cor的过多分泌,实现对神经细胞功能的有效改善。
Efficacy of venlafaxine and fluoxetine in patients with major depressive disorder and anxiety symptoms
Objective To investigate the effects of venlafaxine and fluoxetine on somatic symptoms,sleep quality,serum 5-hydroxytryp-tamine(5-HT),cortisol(Cor)and brain-derived neurotrophic factor(BDNF)levels in patients with major depressive disorder(MDD)and anxiety symptoms.Methods A total of 149 patients with MDD and anxiety symptoms who were admitted to the hospital were divided into control group(74 cases)and study group(75 cases)according to random number table method.The control group was treated with fluoxetine,while the study group was treated with venlafaxine combined with fluoxetine.The clinical effect after 8 weeks of treatment,anxiety,depression,somatic symptoms,sleep quality,serum 5-HT,Cor and BDNF levels,and safety were compared between the groups.Results After 8 weeks of treatment,the treatment response rate in the study group was 97.33%,signifi-cantly higher than 87.84%in the control group(P<0.05).The Hamilton anxiety scale(HAMA)scores,Hamilton depression scale(HAMD)scores,patient health questionnaire-15(PHQ-15)scores,clinical global impression-severity of illness(CGI-S)scores and Pittsburgh sleep quality index(PSQI)scores of the study group were significantly lower than those of the control group(P<0.01).The levels of 5-HT,norepinephrine(NE)and BDNF in the study group were significantly higher than those in the control group(P<0.01),while the level of Cor was significantly lower than that in the control group(P<0.01).There was no statistically significant difference in the incidence of adverse reactions between the 2 groups(P>0.05).Conclusion Venlafaxine combined with fluoxetine is effective in the treatment of patients with MDD and anxiety symptoms.The combined treatment can effectively improve the patients'anxiety symptoms,depression symptoms,somatic symptoms and sleep quality,improve serum 5-HT and BDNF levels,regulate neurotransmitters,inhibit the excessive secretion of cortisol,and effectively improve nerve cells.

venlafaxinefluoxetinemajor depressive disordersomatic symptomsleep quality5-hydroxytryptaminecortisolbrain-derived neurotrophic factor

林荫、赖珏、林春燕、李佳

展开 >

海南省安宁医院精神科三病区,海口 570206

海南省安宁医院精神科七病区,海口 570206

海南省安宁医院精神科二病区,海口 570206

海南省人民医院(海南医学院附属海南医院)精神心理科,海口 570311

展开 >

文拉法辛 氟西汀 重度抑郁症 躯体症状 睡眠质量 5-羟色胺 皮质醇 脑源性神经营养因子

海南省卫生健康行业科研项目

21A200382

2024

西北药学杂志
西安交通大学,陕西省药学会

西北药学杂志

CSTPCD
影响因子:0.912
ISSN:1004-2407
年,卷(期):2024.39(2)
  • 25